本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Dare Bioscience

2.40
0.0000
盘后2.400.00000.00%15:47 EDT
成交量:1.02万
成交额:2.46万
市值:2,124.09万
市盈率:-12.30
高:2.41
开:2.39
低:2.39
收:2.40
数据加载中...
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/08

重要事件披露

8-K - Current report
2021/02/16

重要事件披露

8-K - Current report
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2021/01/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/05

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/23

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/22

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/09

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/18

重要事件披露

8-K - Current report
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]